| Orbimed Advisors Llc |
Non-Executive Director |
Upstream Bio, Inc. (UPB)
|
2024-10-15 |
$17.00 |
0.0% |
825,000
|
$14,025,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
MBX Biosciences, Inc. (MBX)
|
2024-09-16 |
$16.00 |
0.0% |
750,000
|
$12,000,000 |
| Orbimed Advisors Llc |
Non-Executive |
scPharmaceuticals Inc. (SCPH)
|
2024-08-13 |
$4.00 |
29.8% |
500,000
|
$2,000,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Disc Medicine, Inc. (IRON)
|
2024-06-17 |
$36.00 |
39.4% |
83,334
|
$3,000,024 |
| Orbimed Advisors Llc |
Non-Executive Director |
ArriVent Biopharma, Inc. (AVBP)
|
2024-01-30 |
$18.00 |
47.8% |
444,444
|
$7,999,992 |
| Orbimed Advisors Llc |
Non-Executive Director |
Adicet Bio, Inc. (ACET)
|
2024-01-25 |
$2.40 |
-40.0% |
3,125,000
|
$7,500,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Edgewise Therapeutics, Inc. (EWTX)
|
2024-01-23 |
$11.00 |
58.8% |
454,545
|
$4,999,995 |
| Orbimed Advisors Llc |
Non-Executive Director |
ARS Pharmaceuticals, Inc. (SPRY)
|
2023-08-29 |
$6.20 |
89.5% |
500,000
|
$3,100,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Turnstone Biologics Corp. (TSBX)
|
2023-07-20 |
$12.00 |
-94.6% |
416,666
|
$4,999,992 |
| Orbimed Advisors Llc |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2023-07-17 |
$3.05 |
33.1% |
479,932
|
$1,463,793 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2023-06-28 |
$0.84 |
-23.8% |
1,192,577
|
$1,001,765 |
| Orbimed Advisors Llc |
Non-Executive Director |
Adicet Bio, Inc. (ACET)
|
2023-06-27 |
$2.09 |
-31.1% |
875,000
|
$1,828,750 |
| Orbimed Advisors Llc |
Non-Executive Director |
Prelude Therapeutics Inc (PRLD)
|
2023-05-22 |
$5.75 |
-16.3% |
869,565
|
$4,999,999 |
| Orbimed Advisors Llc |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2023-05-05 |
$2.80 |
-5.3% |
1,460,932
|
$4,086,235 |
| Orbimed Advisors Llc |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2023-05-02 |
$2.61 |
1.4% |
1,405,168
|
$3,673,901 |
| Orbimed Advisors Llc |
Non-Executive Director |
Disc Medicine, Inc. (IRON)
|
2023-02-15 |
$23.00 |
118.3% |
108,696
|
$2,500,008 |
| Orbimed Advisors Llc |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-12-23 |
$7.25 |
2.9% |
137,931
|
$1,000,000 |
| Orbimed Advisors Llc |
Non-Executive |
scPharmaceuticals Inc. (SCPH)
|
2022-11-25 |
$5.25 |
-1.1% |
762,380
|
$4,002,495 |
| Orbimed Advisors Llc |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-11-08 |
$3.21 |
-53.6% |
402,000
|
$1,290,420 |
| Orbimed Advisors Llc |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-11-07 |
$5.21 |
-22.1% |
192,000
|
$1,000,320 |
| Orbimed Advisors Llc |
Non-Executive Director |
Third Harmonic Bio, Inc. (THRD)
|
2022-09-19 |
$17.00 |
-29.9% |
300,000
|
$5,100,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Edgewise Therapeutics, Inc. (EWTX)
|
2022-09-16 |
$10.32 |
69.3% |
484,496
|
$4,999,999 |
| Orbimed Advisors Llc |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-08-16 |
$2.42 |
208.3% |
3,690,000
|
$8,929,800 |
| Orbimed Advisors Llc |
Non-Executive Director |
Ikena Oncology, Inc. (IKNA)
|
2022-06-24 |
$4.47 |
-62.9% |
252,225
|
$1,128,021 |
| Orbimed Advisors Llc |
Non-Executive Director |
Edgewise Therapeutics, Inc. (EWTX)
|
2022-05-18 |
$7.21 |
142.3% |
138,000
|
$994,980 |
| Orbimed Advisors Llc |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-05-13 |
$2.18 |
-31.8% |
192,516
|
$420,482 |
| Orbimed Advisors Llc |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2022-05-10 |
$1.57 |
-5.3% |
125,359
|
$197,252 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2022-05-04 |
$1.94 |
-66.9% |
525,000
|
$1,016,285 |
| Orbimed Advisors Llc |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2022-02-15 |
$10.17 |
-73.9% |
195,700
|
$1,989,446 |
| Orbimed Advisors Llc |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-01-21 |
$9.97 |
-59.3% |
158,417
|
$1,578,717 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2022-01-20 |
$5.42 |
-88.2% |
369,100
|
$2,000,522 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2022-01-19 |
$5.38 |
-88.1% |
168,300
|
$905,205 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2022-01-13 |
$5.61 |
-88.6% |
150,000
|
$841,082 |
| Orbimed Advisors Llc |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2022-01-13 |
$9.90 |
-59.0% |
44,717
|
$442,750 |
| Orbimed Advisors Llc |
Non-Executive Director |
Compass Therapeutics, Inc. (CMPX)
|
2021-11-04 |
$3.50 |
-57.4% |
5,357,143
|
$18,750,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Theseus Pharmaceuticals, Inc. (THRX)
|
2021-10-12 |
$16.00 |
-74.6% |
625,000
|
$10,000,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2021-09-17 |
$9.40 |
591.2% |
1,010,637
|
$9,499,988 |
| Orbimed Advisors Llc |
Non-Executive Director |
Acutus Medical, Inc. (AFIB)
|
2021-07-19 |
$14.00 |
-99.8% |
1,071,428
|
$14,999,992 |
| Orbimed Advisors Llc |
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2021-06-15 |
$17.00 |
157.1% |
705,853
|
$11,999,501 |
| Orbimed Advisors Llc |
Non-Executive |
NeuroPace Inc (NPCE)
|
2021-04-21 |
$17.00 |
-57.8% |
235,000
|
$3,995,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Edgewise Therapeutics, Inc. (EWTX)
|
2021-03-30 |
$16.00 |
9.2% |
359,375
|
$5,750,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Ikena Oncology, Inc. (IKNA)
|
2021-03-30 |
$16.00 |
-89.6% |
423,400
|
$6,774,400 |
| Orbimed Advisors Llc |
Non-Executive Director |
Corvus Pharmaceuticals, Inc. (CRVS)
|
2021-02-17 |
$3.50 |
14.3% |
1,285,714
|
$4,499,999 |
| Orbimed Advisors Llc |
Non-Executive Director |
Decibel Therapeutics, Inc. (DBTX)
|
2021-02-17 |
$18.00 |
-72.7% |
1,666,666
|
$29,999,988 |
| Orbimed Advisors Llc |
Non-Executive Director |
Terns Pharmaceuticals, Inc. (TERN)
|
2021-02-09 |
$17.00 |
-56.1% |
475,000
|
$8,075,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Kinnate Biopharma Inc. (KNTE)
|
2020-12-02 |
$20.00 |
-86.8% |
750,000
|
$15,000,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Galecto, Inc. (GLTO)
|
2020-11-02 |
$375.00 |
-96.9% |
29,333
|
$10,999,995 |
| Orbimed Advisors Llc |
Non-Executive Director |
Arcutis Biotherapeutics, Inc. (ARQT)
|
2020-10-02 |
$25.00 |
-56.7% |
496,000
|
$12,400,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
PMV Pharmaceuticals, Inc. (PMVP)
|
2020-09-25 |
$18.00 |
-91.5% |
950,000
|
$17,100,000 |
| Orbimed Advisors Llc |
Non-Executive |
GRAYBUG VISION, INC. (GRAY)
|
2020-09-25 |
$224.00 |
-97.6% |
40,179
|
$9,000,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Prelude Therapeutics Inc (PRLD)
|
2020-09-25 |
$19.00 |
-74.7% |
1,236,800
|
$23,499,200 |
| Orbimed Advisors Llc |
Non-Executive Director |
Acutus Medical, Inc. (AFIB)
|
2020-08-10 |
$18.00 |
-99.8% |
415,000
|
$7,470,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Fusion Pharmaceuticals Inc. (FUSN)
|
2020-06-30 |
$17.00 |
26.8% |
898,000
|
$15,266,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Repare Therapeutics Inc. (RPTX)
|
2020-06-23 |
$20.00 |
-86.3% |
774,200
|
$15,484,000 |
| Orbimed Advisors Llc |
Non-Executive |
scPharmaceuticals Inc. (SCPH)
|
2020-05-21 |
$8.65 |
-40.0% |
1,387,283
|
$11,999,998 |
| Orbimed Advisors Llc |
Non-Executive Director |
Oric Pharmaceuticals, Inc. (ORIC)
|
2020-04-24 |
$16.00 |
-40.8% |
281,250
|
$4,500,000 |
| Orbimed Advisors Llc |
Non-Executive Director |
Keros Therapeutics, Inc. (KROS)
|
2020-04-13 |
$16.00 |
235.5% |
375,200
|
$6,003,200 |
| Orbimed Advisors Llc |
Non-Executive |
Passage BIO, Inc. (PASG)
|
2020-02-28 |
$18.00 |
-96.4% |
373,300
|
$6,719,400 |
| Orbimed Advisors Llc |
Non-Executive Director |
Arcutis Biotherapeutics, Inc. (ARQT)
|
2020-02-03 |
$17.00 |
-36.3% |
558,888
|
$9,501,096 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-16.0% |
$-64,813,121 |
$406,303,985 |